Trigeminal nerve thickening in chronic inflammatory demyelinating polyneuropathy
Bruno Fukelmann Guedes +1 more
doaj +1 more source
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity. [PDF]
Rajabally Z +3 more
europepmc +1 more source
Genetic and metabolic inflammation signatures in chronic inflammatory demyelinating polyneuropathy: the role of IL18 polymorphisms and short-chain fatty acids. [PDF]
Andrusiów S +7 more
europepmc +1 more source
Blood-Nerve Barrier Breakdown Induced by Immunoglobulin G in Typical and Multifocal Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy. [PDF]
Shimizu F +10 more
europepmc +1 more source
Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. [PDF]
Querol L +10 more
europepmc +1 more source
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
Yusuf A Rajabally
doaj +1 more source
Very High Dose Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy: A Multicentre UK Study. [PDF]
Rajabally YA, Freiha J, Min YG, Osman C.
europepmc +1 more source
Lyme neuroborreliosis mimicking primary CNS lymphoma [PDF]
Bise, Karl +4 more
core +1 more source
Development of a PROM set for patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP): study protocol. [PDF]
Pelouto F +3 more
europepmc +1 more source
Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative study. [PDF]
Macwan SP +8 more
europepmc +1 more source

